Multiscale, mechanistic model of Rheumatoid Arthritis to enable decision making in late stage drug development
Abstract Rheumatoid Arthritis (RA) is a chronic autoimmune inflammatory disease that affects about 0.1% to 2% of the population worldwide. Despite the development of several novel therapies, there is only limited benefit for many patients. Thus, there is room for new approaches to improve response t...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Nature Portfolio
2024-11-01
|
| Schriftenreihe: | npj Systems Biology and Applications |
| Online-Zugang: | https://doi.org/10.1038/s41540-024-00454-1 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|